Identification of subtype-specific biomarkers in small cell lung cancer

Informazioni relative al progetto

BIOSMALL

ID dell’accordo di sovvenzione: 101131228

DOI

10.3030/101131228

Data della firma CE 2 Agosto 2023

Data di avvio 1 Ottobre 2023

Data di completamento 30 Settembre 2027

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 897 000,00

Coordinato da

MEDIZINISCHE UNIVERSITAET WIEN
Austria

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Websites, patent fillings, videos etc. (1)

Completion of Website and Social Media Account

We will complete the website and social media account for public information.

Data Management Plan (1)

Data Management Plan

We will prepare the Data Management Plan (DMP) about the handling of research data.

Pubblicazioni

Peer reviewed articles (7)

Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms

Autori: Bence Ferencz, Klára Török, Orsolya Pipek, János Fillinger, Kristóf Csende, András Lantos, Radoslava Černeková, Marcel Mitták, Jozef Škarda, Patricie Delongová, Evelyn Megyesfalvi, Karin Schelch, Christian Lang, Anna Solta, Kristiina Boettiger, Luka Brcic, Jörg Lindenmann, Ferenc Rényi-Vámos, Clemens Aigner, Judit Berta, Zsolt Megyesfalvi, Balázs Döme
Pubblicato in: Cancer Immunology, Immunotherapy, Numero 73, 2024, ISSN 1432-0851
Editore: Springer Science and Business Media LLC
DOI: 10.1007/s00262-024-03704-7

Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation

Autori: Solta, A; Ernhofer, B; Boettiger, K; Lang, C; Megyesfalvi, Z; Mendrina, T; Kirchhofer, D; Timelthaler, G; Szeitz, B; Rezeli, M; Aigner, C; Haschemi, A; Unger, LW; Dome, B; Schelch, K
Pubblicato in: Cancer & Metabolism, Numero 13, 2025, ISSN 2049-3002
Editore: BMC
DOI: 10.1186/S40170-025-00382-6

Comprehensive biobanking strategy with clinical impact at the European Cancer Moonshot Lund Center

Autori: Henriett Oskolas, Fábio C.N. Nogueira, Gilberto B. Domont, Kun-Hsing Yu, Yevgeniy R. Semenov, Peter Sorger, Erik Steinfelder, Les Corps, Lesley Schulz, Elisabet Wieslander, David Fenyö, Sarolta Kárpáti, Péter Holló, Lajos V. Kemény, Balazs Döme, Zsolt Megyesfalvi, Krzysztof Pawłowski, Toshihide Nishimura, HoJeong Kwon, Sergio Encarnación-Guevara, A. Marcell Szasz, Zoltán Veréb, Rolland Gyulai, István Balázs Németh, Roger Appelqvist, Melinda Rezeli, Bo Baldetorp, Peter Horvatovich, Johan Malmström, Indira Pla, Aniel Sanchez, Beatrice Knudsen, András Kiss, Johan Malm, György Marko-Varga, Jeovanis Gil
Pubblicato in: Journal of Proteomics, Numero 316, 2025, ISSN 1874-3919
Editore: Elsevier BV
DOI: 10.1016/J.JPROT.2025.105442

Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

Autori: Anna Solta, Büsra Ernhofer, Kristiina Boettiger, Zsolt Megyesfalvi, Simon Heeke, Mir Alireza Hoda, Christian Lang, Clemens Aigner, Fred R. Hirsch, Karin Schelch, Balazs Döme
Pubblicato in: Molecular Cancer, Numero 23, 2024, ISSN 1476-4598
Editore: Springer Science and Business Media LLC
DOI: 10.1186/S12943-024-01953-9

Prophylactic cranial irradiation for small cell lung cancer in the era of immunotherapy and molecular subtypes

Autori: Veronika Pozonec, Maria Dorothea Pozonec, Clemens Aigner, Joachim Widder, Kristiina Boettiger, Zsolt Megyesfalvi, Balazs Dome
Pubblicato in: Current Opinion in Oncology, Numero 37, 2024, ISSN 1040-8746
Editore: Ovid Technologies (Wolters Kluwer Health)
DOI: 10.1097/CCO.0000000000001111

Expression of costimulatory molecule CD70 is prognostic in small cell lung cancer

Autori: David Dora, Zsolt Megyesfalvi, Imre Vörös, Ágnes Paál, Peter Takacs, Daniela Dobos, Bence Lőrincz, Syeda Mahak Zahra Bokhari, Kenan Aloss, Gergely Pallag, Christopher Rivard, Hui Yu, Fred R. Hirsch, Anikó Görbe, Zoltán V. Varga, Zoltan Lohinai, Balazs Dome
Pubblicato in: Cancer Immunology, Immunotherapy, Numero 74, 2025, ISSN 1432-0851
Editore: Springer Science and Business Media LLC
DOI: 10.1007/S00262-025-04006-2

C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer

Autori: Christian Lang, Zsolt Megyesfalvi, Andras Lantos, Felicitas Oberndorfer, Mir Alireza Hoda, Anna Solta, Bence Ferencz, Janos Fillinger, Anna Solyom-Tisza, Alessandro Saeed Querner, Felix Egger, Kristiina Boettiger, Thomas Klikovits, Gerald Timelthaler, Ferenc Renyi-Vamos, Clemens Aigner, Konrad Hoetzenecker, Viktoria Laszlo, Karin Schelch, Balazs Dome
Pubblicato in: World Journal of Surgical Oncology, Numero 22, 2024, ISSN 1477-7819
Editore: Springer Science and Business Media LLC
DOI: 10.1186/S12957-024-03315-7